Deli Wang
AbbVie (United States)(US)Ministry of Education(RO)China Institute of Veterinary Drug Control(CN)Guangxi Maternal and Child Health Hospital(CN)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Health Systems, Economic Evaluations, Quality of Life, Liver Disease Diagnosis and Treatment, Statistical Methods in Clinical Trials
Most-Cited Works
- → Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease(2016)277 cited
- → Identification of Specific Foods Responsible for Inflammation in Children With Eosinophilic Esophagitis Successfully Treated With Empiric Elimination Diet(2011)253 cited
- → Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial(2021)134 cited
- → Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study(2023)121 cited
- → Quality of Life Evaluation of Maxillomandibular Advancement Surgery for Treatment of Obstructive Sleep Apnea(2008)115 cited
- → Mycophenolate mofetil: A possible therapeutic agent for children with juvenile dermatomyositis(2010)